Literature DB >> 28451851

Obesity-Associated Hypertension: the Upcoming Phenotype in African-American Women.

Rohan Samson1, Andrea Qi1, Abhishek Jaiswal1, Thierry H Le Jemtel2, Suzanne Oparil3.   

Abstract

PURPOSE OF REVIEW: The present obesity epidemic particularly affects African-American women. Whether the obesity epidemic will alter the hypertension phenotype in African-American women is entertained. RECENT
FINDINGS: The prevalence of morbid obesity is steadily increasing in African-American women, who are prone to developing hypertension (HTN) even in the absence of obesity. The obesity-associated hypertension phenotype is characterized by marked sympathetic nervous system activation and resistance/refractoriness to antihypertensive therapy. Weight loss achieved through lifestyle interventions and pharmacotherapy has a modest and rarely sustained antihypertensive effect. In contrast, bariatric surgery has a sustained antihypertensive effect, as evidenced by normalization of hypertension or lessening of antihypertensive therapy. The prevalence of HTN and its obesity-associated phenotype is likely to increase in African-American women over the next decades. Obese African-American women may be increasingly referred for bariatric surgery when hypertension remains uncontrolled despite lifestyle interventions and pharmacological therapy for weight loss and blood pressure (BP) control.

Entities:  

Keywords:  African-American women; Bariatric surgery; Hypertension; Hypertension phenotype; Obesity; Weight loss

Mesh:

Substances:

Year:  2017        PMID: 28451851     DOI: 10.1007/s11906-017-0738-x

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  129 in total

Review 1.  Mechanisms, Pathophysiology, and Management of Obesity.

Authors:  Steven B Heymsfield; Thomas A Wadden
Journal:  N Engl J Med       Date:  2017-01-19       Impact factor: 91.245

2.  Clinical Factors Associated With Remission of Obesity-Related Comorbidities After Bariatric Surgery.

Authors:  Ida J Hatoum; Robin Blackstone; Tina D Hunter; Diane M Francis; Michael Steinbuch; Jason L Harris; Lee M Kaplan
Journal:  JAMA Surg       Date:  2016-02       Impact factor: 14.766

Review 3.  Role of leptin and central nervous system melanocortins in obesity hypertension.

Authors:  Alexandre A da Silva; Jussara M do Carmo; John E Hall
Journal:  Curr Opin Nephrol Hypertens       Date:  2013-03       Impact factor: 2.894

4.  Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial.

Authors:  Lawrence J Appel; Catherine M Champagne; David W Harsha; Lawton S Cooper; Eva Obarzanek; Patricia J Elmer; Victor J Stevens; William M Vollmer; Pao-Hwa Lin; Laura P Svetkey; Sarah W Stedman; Deborah R Young
Journal:  JAMA       Date:  2003 Apr 23-30       Impact factor: 56.272

5.  Obesity and Black Women: Special Considerations Related to Genesis and Therapeutic Approaches.

Authors:  Priscilla Agyemang; Tiffany M Powell-Wiley
Journal:  Curr Cardiovasc Risk Rep       Date:  2013-10-01

6.  Prevalence of overweight and obesity in the United States, 1999-2004.

Authors:  Cynthia L Ogden; Margaret D Carroll; Lester R Curtin; Margaret A McDowell; Carolyn J Tabak; Katherine M Flegal
Journal:  JAMA       Date:  2006-04-05       Impact factor: 56.272

7.  Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.

Authors:  David A Calhoun; Daniel Jones; Stephen Textor; David C Goff; Timothy P Murphy; Robert D Toto; Anthony White; William C Cushman; William White; Domenic Sica; Keith Ferdinand; Thomas D Giles; Bonita Falkner; Robert M Carey
Journal:  Hypertension       Date:  2008-04-07       Impact factor: 10.190

Review 8.  Treatment of hypertension in obese patients.

Authors:  Srividya Kidambi; Theodore A Kotchen
Journal:  Am J Cardiovasc Drugs       Date:  2013-06       Impact factor: 3.571

9.  Nedd4-2 and the regulation of epithelial sodium transport.

Authors:  Daniela Rotin; Olivier Staub
Journal:  Front Physiol       Date:  2012-06-21       Impact factor: 4.566

10.  Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial.

Authors:  Bryan Williams; Thomas M MacDonald; Steve Morant; David J Webb; Peter Sever; Gordon McInnes; Ian Ford; J Kennedy Cruickshank; Mark J Caulfield; Jackie Salsbury; Isla Mackenzie; Sandosh Padmanabhan; Morris J Brown
Journal:  Lancet       Date:  2015-09-20       Impact factor: 79.321

View more
  2 in total

Review 1.  Hypertension in Premenopausal and Postmenopausal Women.

Authors:  Yasmin Brahmbhatt; Maitreyee Gupta; Seyed Hamrahian
Journal:  Curr Hypertens Rep       Date:  2019-08-26       Impact factor: 5.369

2.  Mitochondrial inefficiency in infants born to overweight African-American mothers.

Authors:  Manjusha Abraham; Christina A Collins; Scott Flewelling; Maraya Camazine; Alison Cahill; W Todd Cade; Jennifer G Duncan
Journal:  Int J Obes (Lond)       Date:  2018-03-03       Impact factor: 5.095

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.